Nautilus Biotechnology Statistics
Total Valuation
NAUT has a market cap or net worth of $91.21 million. The enterprise value is -$18.26 million.
Important Dates
The last earnings date was Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NAUT has 126.15 million shares outstanding. The number of shares has increased by 0.50% in one year.
| Current Share Class | 126.15M |
| Shares Outstanding | 126.15M |
| Shares Change (YoY) | +0.50% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 32.22% |
| Owned by Institutions (%) | 19.80% |
| Float | 46.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.36, with a Debt / Equity ratio of 0.15.
| Current Ratio | 17.36 |
| Quick Ratio | 17.02 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -30.93% and return on invested capital (ROIC) is -19.41%.
| Return on Equity (ROE) | -30.93% |
| Return on Assets (ROA) | -19.06% |
| Return on Invested Capital (ROIC) | -19.41% |
| Return on Capital Employed (ROCE) | -35.85% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$442,987 |
| Employee Count | 155 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.61% in the last 52 weeks. The beta is 1.23, so NAUT's price volatility has been higher than the market average.
| Beta (5Y) | 1.23 |
| 52-Week Price Change | -73.61% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 44.85 |
| Average Volume (20 Days) | 170,444 |
Short Selling Information
The latest short interest is 867,410, so 0.69% of the outstanding shares have been sold short.
| Short Interest | 867,410 |
| Short Previous Month | 548,875 |
| Short % of Shares Out | 0.69% |
| Short % of Float | 1.86% |
| Short Ratio (days to cover) | 2.93 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -78.71M |
| Pretax Income | -69.64M |
| Net Income | -68.66M |
| EBITDA | -76.79M |
| EBIT | -78.71M |
| Earnings Per Share (EPS) | -$0.55 |
Full Income StatementBalance Sheet
The company has $138.81 million in cash and $29.34 million in debt, giving a net cash position of $109.47 million or $0.87 per share.
| Cash & Cash Equivalents | 138.81M |
| Total Debt | 29.34M |
| Net Cash | 109.47M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 194.44M |
| Book Value Per Share | 1.54 |
| Working Capital | 133.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$56.82 million and capital expenditures -$2.45 million, giving a free cash flow of -$59.27 million.
| Operating Cash Flow | -56.82M |
| Capital Expenditures | -2.45M |
| Free Cash Flow | -59.27M |
| FCF Per Share | -$0.47 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |